Tabula Rasa HealthCare (TRHC) Lowered to “Hold” at BidaskClub

Share on StockTwits

BidaskClub cut shares of Tabula Rasa HealthCare (NASDAQ:TRHC) from a buy rating to a hold rating in a research report sent to investors on Saturday.

A number of other research analysts also recently issued reports on TRHC. Robert W. Baird reiterated a buy rating and set a $70.00 target price on shares of Tabula Rasa HealthCare in a research report on Wednesday, August 8th. Piper Jaffray Companies boosted their target price on shares of Tabula Rasa HealthCare to $71.00 and gave the company an overweight rating in a research report on Wednesday, August 8th. Citigroup boosted their target price on shares of Tabula Rasa HealthCare from $57.00 to $76.00 and gave the company a buy rating in a research report on Thursday, August 9th. Zacks Investment Research upgraded shares of Tabula Rasa HealthCare from a hold rating to a buy rating and set a $74.00 price objective on the stock in a report on Saturday, August 11th. Finally, Oppenheimer upped their price objective on shares of Tabula Rasa HealthCare from $65.00 to $86.00 and gave the stock an outperform rating in a report on Thursday, August 23rd. Three investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The stock presently has a consensus rating of Buy and an average target price of $75.82.

Tabula Rasa HealthCare stock opened at $71.77 on Friday. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.33 and a current ratio of 0.36. Tabula Rasa HealthCare has a 12-month low of $26.02 and a 12-month high of $91.16. The firm has a market cap of $1.36 billion, a P/E ratio of -1,794.25, a P/E/G ratio of 5.06 and a beta of 2.85.

Tabula Rasa HealthCare (NASDAQ:TRHC) last released its earnings results on Tuesday, August 7th. The company reported $0.20 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.08 by $0.12. Tabula Rasa HealthCare had a negative net margin of 16.78% and a positive return on equity of 4.55%. The company had revenue of $48.60 million for the quarter, compared to the consensus estimate of $46.73 million. On average, equities research analysts expect that Tabula Rasa HealthCare will post 0.53 EPS for the current fiscal year.

In other Tabula Rasa HealthCare news, President Orsula V. Knowlton sold 8,000 shares of the company’s stock in a transaction on Friday, August 17th. The shares were sold at an average price of $72.23, for a total transaction of $577,840.00. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In the last 90 days, insiders have sold 48,000 shares of company stock worth $3,630,240. Corporate insiders own 14.00% of the company’s stock.

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Mount Yale Investment Advisors LLC acquired a new position in Tabula Rasa HealthCare during the second quarter worth $111,000. Meadow Creek Investment Management LLC bought a new stake in shares of Tabula Rasa HealthCare in the 2nd quarter worth $115,000. Envestnet Asset Management Inc. bought a new stake in shares of Tabula Rasa HealthCare in the 2nd quarter worth $130,000. Mckinley Capital Management LLC Delaware grew its stake in shares of Tabula Rasa HealthCare by 60.5% in the 2nd quarter. Mckinley Capital Management LLC Delaware now owns 2,431 shares of the company’s stock worth $155,000 after acquiring an additional 916 shares in the last quarter. Finally, Pinebridge Investments L.P. bought a new stake in shares of Tabula Rasa HealthCare in the 2nd quarter worth $181,000. Hedge funds and other institutional investors own 75.17% of the company’s stock.

Tabula Rasa HealthCare Company Profile

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.

Further Reading: Tariff

Analyst Recommendations for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply